Bottom line
What does GDOC hold?
GDOC held 42 positions as of May 31, 2026. Its largest holding is Eli Lilly & Company at 13.28% of the fund, and the top 10 positions add up to 57.3%. By asset type it is 98% stocks, 1% cash & short-term funds.
Updated Jul 24, 2026
GDOC top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Company LLY ELI LILLY & COMPANY COM |
Stocks | 13.28% | $2.7M |
| 2 | Johnson & Johnson JNJ JOHNSON & JOHNSON COM |
Stocks | 8.07% | $1.6M |
| 3 | Merck & Company Inc MRK MERCK & COMPANY INC COM |
Stocks | 5.94% | $1.2M |
| 4 | Guardant Health Inc GH GUARDANT HEALTH INC COM |
Stocks | 5.34% | $1.1M |
| 5 | Astrazeneca Plc AZN ASTRAZENECA PLC ORD USD0.25 |
Stocks | 4.84% | $973.8K |
| 6 | Thermo Fisher Scientific Inc TMO THERMO FISHER SCIENTIFIC INC COM |
Stocks | 4.52% | $909.7K |
| 7 | Argenx Se ARGX ARGENX SE SPONSORED ADR |
Stocks | 4.07% | $818.4K |
| 8 | Intuitive Surgical Inc ISRG INTUITIVE SURGICAL INC COM NEW |
Stocks | 3.90% | $785.2K |
| 9 | Boston Scientific Corp BSX BOSTON SCIENTIFIC CORP COM |
Stocks | 3.78% | $760.4K |
| 10 | Hoya Corp 7741 HOYA CORP NPV |
Stocks | 3.53% | $709.9K |
| 11 | Edwards Lifesciences Corp EW EDWARDS LIFESCIENCES CORP COM |
Stocks | 2.98% | $600.0K |
| 12 | Lonza Group Ag LONN LONZA GROUP AG CHF1 (REGD) |
Stocks | 2.80% | $562.9K |
| 13 | Dexcom Inc DXCM DEXCOM INC COM |
Stocks | 2.79% | $562.0K |
| 14 | Agilent Technologies Inc A AGILENT TECHNOLOGIES INC COM |
Stocks | 2.77% | $556.4K |
| 15 | Roivant Sciences Ltd ROIV ROIVANT SCIENCES LTD SHS |
Stocks | 2.39% | $480.9K |
| 16 | Cencora Inc COR CENCORA INC COM |
Stocks | 2.34% | $471.4K |
| 17 | Apogee Therapeutics Inc APGE APOGEE THERAPEUTICS INC COM |
Stocks | 1.97% | $396.2K |
| 18 | Royalty Pharma Plc RPRX ROYALTY PHARMA PLC COM USD0.0001 CLASS A |
Stocks | 1.77% | $355.2K |
| 19 | Penumbra Inc PEN PENUMBRA INC COM |
Stocks | 1.61% | $323.1K |
| 20 | Mettler-toledo International Inc MTD METTLER-TOLEDO INTERNATIONAL INC COM |
Stocks | 1.59% | $319.9K |
| 21 | Vertex Pharmaceuticals Inc VRTX VERTEX PHARMACEUTICALS INC COM |
Stocks | 1.48% | $298.5K |
| 22 | Goldman Sachs Trust Goldman Sachs Financial Square Treasury Obligations Fund |
Cash & short-term funds | 1.43% | $288.0K |
| 23 | Cytokinetics Inc CYTK CYTOKINETICS INC COM NEW |
Stocks | 1.40% | $281.2K |
| 24 | Ionis Pharmaceuticals Inc IONS IONIS PHARMACEUTICALS INC COM |
Stocks | 1.37% | $276.5K |
| 25 | Xenon Pharmaceuticals Inc XENE XENON PHARMACEUTICALS INC COM |
Stocks | 1.35% | $272.4K |
Source: SEC Form N-PORT, period ended May 31, 2026, filed Jul 24, 2026